The use of alternative medicine（AM） in Australia dates back to its earliest times,with the indigenous medicine of the aboriginal peoples and the folk medicine of the early English settlers.AM has until recently exis...The use of alternative medicine（AM） in Australia dates back to its earliest times,with the indigenous medicine of the aboriginal peoples and the folk medicine of the early English settlers.AM has until recently existed quite separately from Western biomedicine（WB） and there has been little integration of the two systems.Now,referred to as complementary medicine（CM）,there has been a movement over the last 20 years to include CM in WB mainstream practices.Varying degrees of success have been reported but for the discipline of oncology.Medical oncology（MO） in Australia is demanding CM provide high levels of evidence for any inclusion in cancer protocols.There are just now the beginnings of this integration, particularly as CM is now being taught in the public university system to a PhD level as well as the public demand for their medical doctors to communicate with their CM practitioners.MO specialists are now open to a dialogue with their CM counterparts.展开更多
目的:探讨中西医结合治疗分泌性中耳炎的临床疗效及安全性。方法:选取2014年1月—2015年1月期间于医院接受检查并确诊的94例分泌性中耳炎患者为研究对象,按照就诊顺序随机分为两组,各47例。对照组患者采取单纯西医治疗,观察组患者采取...目的:探讨中西医结合治疗分泌性中耳炎的临床疗效及安全性。方法:选取2014年1月—2015年1月期间于医院接受检查并确诊的94例分泌性中耳炎患者为研究对象,按照就诊顺序随机分为两组,各47例。对照组患者采取单纯西医治疗,观察组患者采取中西医结合治疗,对比临床治疗效果及不良反应发生情况。结果:观察组治愈率为67.86%,有效率为95.74%与对照组治愈率(45.76%)和有效率(76.60%)比较均有明显提高,差异显著(P<0.05)。治疗后,观察组患者纯音气导听阈(25.11±9.96)d B HL和气骨导差(3.48±1.96)d B HL与治疗前和对照组比较均有明显降低,差异显著(P<0.05)。随访期间,观察组患者复发率为4.26%,与对照组19.15%比较有明显提高,差异显著(P<0.05)。观察组患者不良反应发生率为8.51%,与对照组23.40%比较有明显降低,差异显著(P<0.05)。结论:中西医结合治疗分泌性中耳炎疗效显著,能够有效提高患者治愈率,改善其听力学指标,且复发率较低,不良反应较少,安全性高,值得临床推广和应用。展开更多
文摘The use of alternative medicine（AM） in Australia dates back to its earliest times,with the indigenous medicine of the aboriginal peoples and the folk medicine of the early English settlers.AM has until recently existed quite separately from Western biomedicine（WB） and there has been little integration of the two systems.Now,referred to as complementary medicine（CM）,there has been a movement over the last 20 years to include CM in WB mainstream practices.Varying degrees of success have been reported but for the discipline of oncology.Medical oncology（MO） in Australia is demanding CM provide high levels of evidence for any inclusion in cancer protocols.There are just now the beginnings of this integration, particularly as CM is now being taught in the public university system to a PhD level as well as the public demand for their medical doctors to communicate with their CM practitioners.MO specialists are now open to a dialogue with their CM counterparts.
文摘目的:探讨中西医结合治疗分泌性中耳炎的临床疗效及安全性。方法:选取2014年1月—2015年1月期间于医院接受检查并确诊的94例分泌性中耳炎患者为研究对象,按照就诊顺序随机分为两组,各47例。对照组患者采取单纯西医治疗,观察组患者采取中西医结合治疗,对比临床治疗效果及不良反应发生情况。结果:观察组治愈率为67.86%,有效率为95.74%与对照组治愈率(45.76%)和有效率(76.60%)比较均有明显提高,差异显著(P<0.05)。治疗后,观察组患者纯音气导听阈(25.11±9.96)d B HL和气骨导差(3.48±1.96)d B HL与治疗前和对照组比较均有明显降低,差异显著(P<0.05)。随访期间,观察组患者复发率为4.26%,与对照组19.15%比较有明显提高,差异显著(P<0.05)。观察组患者不良反应发生率为8.51%,与对照组23.40%比较有明显降低,差异显著(P<0.05)。结论:中西医结合治疗分泌性中耳炎疗效显著,能够有效提高患者治愈率,改善其听力学指标,且复发率较低,不良反应较少,安全性高,值得临床推广和应用。
